Todd Jensen, MD
Internal Medicine · Des Moines, IANPI 1952396616
Payments from drug & device makers
Across 601 payments — averaging $14.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Amgen$758
- Takeda Pharmaceuticals U.S.A., Inc.$755
- Pfizer$731
- AstraZeneca$671
- Boehringer Ingelheim$598
- plus $4K from 21 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 104 | $1,582 |
| Amgen | 53 | $758 |
| Takeda Pharmaceuticals U.S.A., Inc. | 73 | $755 |
| Pfizer | 56 | $731 |
| AstraZeneca | 35 | $671 |
| Boehringer Ingelheim | 36 | $598 |
| Lilly USA, LLC | 33 | $595 |
| Novartis | 33 | $459 |
| Merck | 33 | $412 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 28 | $341 |
| E.r. Squibb & Sons, L.L.C. | 27 | $332 |
| Novo Nordisk | 19 | $313 |
| Bayer | 13 | $198 |
| Nestle Healthcare Nutrition Inc. | 10 | $194 |
| Biohaven Pharmaceutical Holding Company Ltd. | 11 | $190 |
| Teva Pharmaceuticals USA, Inc. | 9 | $145 |
| Johnson & Johnson | 5 | $106 |
| Ironwood Pharmaceuticals, Inc | 5 | $84 |
| Otsuka America Pharmaceutical, Inc. | 4 | $73 |
| Biohaven Pharmaceuticals, Inc. | 3 | $49 |
| Eisai Inc. | 3 | $34 |
| Astellas Pharma US Inc | 2 | $32 |
| Idorsia Pharmaceuticals US Inc | 2 | $32 |
| GSK | 1 | $19 |
| Lundbeck LLC | 1 | $19 |
| Mylan Specialty L.p. | 1 | $15 |
| Acadia Pharmaceuticals Inc | 1 | $13 |
How this compares
$8,749 in reported general payments places this provider in the 95th percentile of 583 internal medicine providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in Des Moines
- Ryan TomlinsonDes Moines$209K
- Leatrice OlsonDes Moines$9K
- Louise ConveryDes Moines$8K
- Laura KerseyDes Moines$8K
- Anthonia IjeliDes Moines$7K
- Omar JaradatDes Moines$4K
- Garrett WiltDes Moines$4K
- Kyle ClayDes Moines$3K
- Tyler MummDes Moines$2K
- Justin BergerDes Moines$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.